NCT04115982

Brief Summary

Digital nerve injuries are frequent in a FESUM center (Federation Européenne des Services d'Urgences Mains), and they need to be repaired in order to reduce the risk of hypoesthesia and to prevent painful neuroma. Several animal studies have shown that Cholecalciferol improves axonal nerve regeneration and myelination. No study has ever been done on human subjects to evaluate the nerve regeneration after Cholecalciferol supplementation. Our hypothesis is that Cholecalciferol supplementation could improve axonal nerve regeneration and myelination after traumatic digital nerve injuries treated by microsurgical sutures and reduce the risk of hypoesthesia and neuroma.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2020

Typical duration for phase_3

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 4, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

January 20, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 31, 2021

Status Verified

July 1, 2021

Enrollment Period

2.9 years

First QC Date

August 19, 2019

Last Update Submit

August 30, 2021

Conditions

Keywords

digital nerve injuryneuromacholecalciferol

Outcome Measures

Primary Outcomes (1)

  • Weber test (Month 6)

    2 point discrimination test of Weber on the side of the fingertip concerned by the wound, comparing to the controlateral arm, after 6 months.

    Month 6

Secondary Outcomes (10)

  • Weber test (Month 12)

    Month 12

  • Resting pain on the operated finger

    Month 2, Month 6, Month 12

  • Neuropathic pain on the operated finger

    Month 2, Month 6, Month 12

  • Global functional outcome measure

    Month 2, Month 6, Month 12

  • Cold Intolerance

    Month 2, Month 6, Month 12

  • +5 more secondary outcomes

Study Arms (2)

Cholecalciferol

EXPERIMENTAL

Cholecalciferol (Vitamin D3) 100 000 IU/2 mL

Drug: Cholecalciferol

Placebo

PLACEBO COMPARATOR

Placebo of Cholecalciferol (Vitamine D3) 100 000 IU/2 mL

Drug: Placebos

Interventions

One vial every 15 days during 2 months

Cholecalciferol

One vial every 15 days during 2 months

Placebo

Eligibility Criteria

Age18 Years - 51 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Affiliated to social security scheme,
  • Wound of the palmar hand with isolated digital nerve section, requiring digital nerve microsurgical suture in the operating room by a senior surgeon,
  • Signing a free and informed consent and well-informed of the study and procedure.

You may not qualify if:

  • Ischemia,
  • Multiple lesion of the same nerve,
  • Pregnant or nursing women,
  • Contraindication of Cholecalciferol : known hypersensitivity, any history of hypercalcemia, hypercalciuria or renal lithiasis,
  • Cholecalciferol supplementation in the past 6 months,
  • Lesion of the same controlateral finger,
  • History of nerve lesion or hypoesthesia on the same finger,
  • History of previous neurological disorders with upper limb sensitivity disorder,
  • Impossibility to undergo the medical follow-up because of geographical, social or psychological reason,
  • Participation in another clinical trial that does not allow simultaneous participation in several clinical trials,
  • Orlistat® Treatment,
  • History of celiac disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Caen University Hospital

Caen, 14000, France

RECRUITING

Rouen University Hospital

Rouen, 76000, France

RECRUITING

Institut de la main Nantes Atlantique

Saint-Herblain, 44800, France

RECRUITING

Related Publications (26)

  • al-Ghazal SK, McKiernan M, Khan K, McCann J. Results of clinical assessment after primary digital nerve repair. J Hand Surg Br. 1994 Apr;19(2):255-7. doi: 10.1016/0266-7681(94)90180-5.

    PMID: 8014564BACKGROUND
  • Alligand-Perrin P, Rabarin F, Jeudy J, Cesari B, Saint-Cast Y, Fouque PA, Raimbeau G. Vein conduit associated with microsurgical suture for complete collateral digital nerve severance. Orthop Traumatol Surg Res. 2011 Jun;97(4 Suppl):S16-20. doi: 10.1016/j.otsr.2011.03.012. Epub 2011 Apr 30.

    PMID: 21531189BACKGROUND
  • Arnaout A, Fontaine C, Chantelot C. Sensory recovery after primary repair of palmar digital nerves using a Revolnerv((R)) collagen conduit: a prospective series of 27 cases. Chir Main. 2014 Sep;33(4):279-85. doi: 10.1016/j.main.2014.05.002. Epub 2014 Jun 18.

    PMID: 25169199BACKGROUND
  • Barrueto F Jr, Wang-Flores HH, Howland MA, Hoffman RS, Nelson LS. Acute vitamin D intoxication in a child. Pediatrics. 2005 Sep;116(3):e453-6. doi: 10.1542/peds.2004-2580.

    PMID: 16140692BACKGROUND
  • Battiston B, Geuna S, Ferrero M, Tos P. Nerve repair by means of tubulization: literature review and personal clinical experience comparing biological and synthetic conduits for sensory nerve repair. Microsurgery. 2005;25(4):258-67. doi: 10.1002/micr.20127.

    PMID: 15934044BACKGROUND
  • Bertleff MJ, Meek MF, Nicolai JP. A prospective clinical evaluation of biodegradable neurolac nerve guides for sensory nerve repair in the hand. J Hand Surg Am. 2005 May;30(3):513-8. doi: 10.1016/j.jhsa.2004.12.009.

    PMID: 15925161BACKGROUND
  • Chabas JF, Stephan D, Marqueste T, Garcia S, Lavaut MN, Nguyen C, Legre R, Khrestchatisky M, Decherchi P, Feron F. Cholecalciferol (vitamin D(3)) improves myelination and recovery after nerve injury. PLoS One. 2013 May 31;8(5):e65034. doi: 10.1371/journal.pone.0065034. Print 2013.

    PMID: 23741446BACKGROUND
  • Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003 Jan;77(1):204-10. doi: 10.1093/ajcn/77.1.204.

    PMID: 12499343BACKGROUND
  • Neubrech F, Heider S, Otte M, Hirche C, Kneser U, Kremer T. [Nerve Tubes for the Repair of Traumatic Sensory Nerve Lesions of the Hand: Review and Planning Study for a Randomised Controlled Multicentre Trial]. Handchir Mikrochir Plast Chir. 2016 Jun;48(3):148-54. doi: 10.1055/s-0042-104505. Epub 2016 Jun 16. German.

    PMID: 27311073BACKGROUND
  • Finnell JT, Knopp R, Johnson P, Holland PC, Schubert W. A calibrated paper clip is a reliable measure of two-point discrimination. Acad Emerg Med. 2004 Jun;11(6):710-4.

    PMID: 15175216BACKGROUND
  • Gueye Y, Marqueste T, Maurel F, Khrestchatisky M, Decherchi P, Feron F. Cholecalciferol (vitamin D(3)) improves functional recovery when delivered during the acute phase after a spinal cord trauma. J Steroid Biochem Mol Biol. 2015 Nov;154:23-31. doi: 10.1016/j.jsbmb.2015.06.007. Epub 2015 Jul 6.

    PMID: 26159913BACKGROUND
  • Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab. 2002 Nov;87(11):4952-6. doi: 10.1210/jc.2002-020636.

    PMID: 12414856BACKGROUND
  • Lundborg G, Rosen B. The two-point discrimination test--time for a re-appraisal? J Hand Surg Br. 2004 Oct;29(5):418-22. doi: 10.1016/j.jhsb.2004.02.008.

    PMID: 15336741BACKGROUND
  • Fakin RM, Calcagni M, Klein HJ, Giovanoli P. Long-term clinical outcome after epineural coaptation of digital nerves. J Hand Surg Eur Vol. 2016 Feb;41(2):148-54. doi: 10.1177/1753193415578986. Epub 2015 Mar 31.

    PMID: 25827143BACKGROUND
  • Manoli T, Schiefer JL, Schulz L, Fuchsberger T, Schaller HE. Influence of immobilization and sensory re-education on the sensory recovery after reconstruction of digital nerves with direct suture or muscle-in-vein conduits. Neural Regen Res. 2016 Feb;11(2):338-44. doi: 10.4103/1673-5374.169638.

    PMID: 27073390BACKGROUND
  • Montava M, Garcia S, Mancini J, Jammes Y, Courageot J, Lavieille JP, Feron F. Vitamin D3 potentiates myelination and recovery after facial nerve injury. Eur Arch Otorhinolaryngol. 2015 Oct;272(10):2815-23. doi: 10.1007/s00405-014-3305-y. Epub 2014 Sep 27.

    PMID: 25261104BACKGROUND
  • Pomares G, Dap F, Dautel G. Complete section of proper palmar digital pedicles: Correlation between arterial patency and sensory recovery. Hand Surg Rehabil. 2017 Apr;36(2):136-140. doi: 10.1016/j.hansur.2016.12.001. Epub 2017 Mar 9.

    PMID: 28325428BACKGROUND
  • Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int. 2008 Nov;19(11):1621-8. doi: 10.1007/s00198-008-0619-x. Epub 2008 Apr 18.

    PMID: 18421544BACKGROUND
  • Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008 Aug;93(8):3015-20. doi: 10.1210/jc.2008-0350. Epub 2008 May 20.

    PMID: 18492750BACKGROUND
  • Shimokata H, Kuzuya F. Two-point discrimination test of the skin as an index of sensory aging. Gerontology. 1995;41(5):267-72. doi: 10.1159/000213693.

    PMID: 8537010BACKGROUND
  • Shooter D. Use of two-point discrimination as a nerve repair assessment tool: preliminary report. ANZ J Surg. 2005 Oct;75(10):866-8. doi: 10.1111/j.1445-2197.2005.03557.x.

    PMID: 16176227BACKGROUND
  • Taylor PN, Davies JS. A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018 Jun;84(6):1121-1127. doi: 10.1111/bcp.13573. Epub 2018 Apr 16.

    PMID: 29498758BACKGROUND
  • Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 May;69(5):842-56. doi: 10.1093/ajcn/69.5.842.

    PMID: 10232622BACKGROUND
  • Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):575-9. doi: 10.1016/j.jsbmb.2004.03.038.

    PMID: 15225842BACKGROUND
  • Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001 Feb;73(2):288-94. doi: 10.1093/ajcn/73.2.288.

    PMID: 11157326BACKGROUND
  • Vieth R, Pinto TR, Reen BS, Wong MM. Vitamin D poisoning by table sugar. Lancet. 2002 Feb 23;359(9307):672. doi: 10.1016/S0140-6736(02)07814-5. No abstract available.

    PMID: 11879864BACKGROUND

MeSH Terms

Conditions

Neuroma

Interventions

Cholecalciferol

Condition Hierarchy (Ancestors)

Nerve Sheath NeoplasmsNeoplasms, Nerve TissueNeoplasms by Histologic TypeNeoplasms

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Central Study Contacts

Flore-Anne Lecoq, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2019

First Posted

October 4, 2019

Study Start

January 20, 2020

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

August 31, 2021

Record last verified: 2021-07

Locations